ESC 365 - Use of sacubitril-valsartan in an extensive long term follow up cohort in real life

ESC Premium Access

Use of sacubitril-valsartan in an extensive long term follow up cohort in real life

Session: Poster Session 1 - Treatment of the chronic heart failure

Topic: Pharmacotherapy

Speaker: Doctor A. Garcia Quintana (Palmas de Gran Canaria, Las, ES)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Antonio Garcia Quintana

University Hospital of Gran Canaria Dr. Negrin, Palmas de Gran Canaria, Las (Spain)

1 presentation

0 follower

9 more presentations in this session

Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

Speaker: Doctor A. Kozynacka (Krakow, PL)

Effect of sacubitril-valsartan in reducing physical frailty in patients with advanced heart failure in waiting list for heart transplantation

Speaker: Doctor G. Benincasa (Naples, IT)

Changes in glycated hemoglobin in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan

Valsartan reduces level of soluble ST2 and left ventricle remodeling in patients with dual chamber pacemaker

Speaker: Mrs E. Radzik (Zabrze, PL)

Eligible patients for the PARADIGM-HF trial in a real-world outpatient clinic and its cardiovascular risk

Speaker: Doctor X. Chen (Chengdu, CN)

Access the full session

Poster Session 1 - Treatment of the chronic heart failure

Speakers: Doctor A. Garcia Quintana, Doctor A. Kozynacka, Doctor G. Benincasa, Mrs E. Radzik, Doctor X. Chen

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources